Delivery Order SPE2DB24D9144-SPE2DB24FCMJF

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with an ultimate completion date of September 6, 2024, is for the supply of XTANDI 40 MG TABLET 120S. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XTANDI 40 MG CAPSULE 120S, with a period of performance through August 12, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,321.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 1, 2022, is for the supply of 4557937756 - XTANDI 40 MG CAPSULE 120S. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group, which runs...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to place orders for a comprehensive range of pharmaceutical products to support the medical...
The U.S. government has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,169.59, is for the delivery of XTANDI 80 MG TABLET 60S to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $12,508.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which does not have a set-aside designation, is for the delivery of Xtandi 40 mg tablets (120 count) and is a firm fixed-price order. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic...
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order worth $25,868.10 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for 120 capsules of the pharmaceutical product XTANDI 40 MG and has a completion date of February 7, 2024. This order is placed under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025, which enables the DLA to...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,134,628 units of the prescription medication XTANDI 80 MG TABLET 60S, with a completion date of October 18, 2024. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 units of the drug Xtandi (40 mg capsules) with a period of performance ending on October 24, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,508.77 contract is for the delivery of XTANDI 80 MG TABLET 60S, a specialized prescription medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMJF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 5, 2024, is for the delivery of XTANDI 80 MG TABLET 60S, a pharmaceutical product. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group Inc. holds with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical needs of military health facilities worldwide.

Generated 11/1/24, 10:28 AM